All Stories

  1. Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age-matched controls
  2. Pain assessment and management in haemophilia: A survey among Italian patients and specialist physicians
  3. The socioeconomic burden of patients affected by hemophilia with inhibitors
  4. Comorbidities in persons with haemophilia aged 60 years or more compared with age-matched people from the general population
  5. Cost-effectiveness analysis of late prophylaxis vs. on-demand treatment for severe haemophilia A in Italy
  6. Safety of Switching Factor VIII Products in the Era of Evolving Concentrates: Myths and Facts
  7. Oral Anticoagulant Drugs and the Risk of Osteoporosis: New Anticoagulants Better than Old?
  8. Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery
  9. Old and New Challenges in Hemophilia Management
  10. Arthropathy in Patients with Moderate Hemophilia A: A Systematic Review of the Literature
  11. Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C (and Congenital Bleeding Disorders): Where Do We Stand?
  12. FEIBA versus NovoSeven in Hemophilia Patients with Inhibitors
  13. Treatment for preventing bleeding in people with congenital bleeding disorders undergoing surgery
  14. Thrombotic and Hemorrhagic Syndromes Associated with Autoimmunity and Infection
  15. Acquired Inhibitors of Coagulation Factors: Part I—Acquired Hemophilia A
  16. The Infectious Burden in Atherothrombosis
  17. Cardiovascular Risk in Rheumatic Patients: The Link between Inflammation and Atherothrombosis
  18. Atherothrombosis in von Willebrand Disease: An Analysis of the Literature and Implications for Clinical Management
  19. Prophylaxis in Children with Hemophilia: Evidence-Based Achievements, Old and New Challenges
  20. Bleeding and Thrombosis in Multiple Myeloma and Related Plasma Cell Disorders
  21. Genotype-independent in vivo oxidative stress following a methionine loading test: Maximal platelet activation in subjects with early-onset thrombosis
  22. Preventing Postsurgical Venous Thromboembolism: Pharmacological Approaches
  23. Optimizing management of immune tolerance induction in patients with severe haemophilia A and inhibitors: towards evidence‐based approaches
  24. Treatment of hemophilia: a review of current advances and ongoing issues
  25. Disseminated Intravascular Coagulation in Hematologic Malignancies
  26. The Management of Cardiovascular Diseases in Patients with Hemophilia
  27. Inherited Thrombophilia: Implications for Prevention and Treatment of Venous Thromboembolism
  28. Glanzmann’s thrombasthenia (defective platelet integrin αIIb-β3): proposals for management between evidence and open issues
  29. Cardiovascular risk factors and outcome in patients with retinal vein occlusion
  30. Acquired Hemophilia: An Overview on Diagnosis and Treatment
  31. Prophylaxis in people with haemophilia
  32. Recombinant activated factor VII for hemostatic cover of orthopedic interventions in a girl with thrombocytopenia with absent radii syndrome
  33. Haemophilia A: molecular insights
  34. Predisposing factors in patients with early-onset cerebral vein thrombosis
  35. Haemophilia B: From Molecular Diagnosis to Gene Therapy
  36. Erratum: MTHFR C677T and A1298C polymorphisms and mutated sequences occurring in cis
  37. No association between the MTHFR A1298C and transcobalamin C776G genetic polymorphisms and hyperhomocysteinemia in thrombotic disease
  38. Severe pancytopenia and intrahepatic cholestasis in a patient with a history of Hodgkin’s disease.
  39. G20210A prothrombin gene mutation and other trombophilic polymorphisms in patients with portal or hepatic venous thrombosis
  40. Homocysteine, Coagulation, Platelet Function, and Thrombosis